Clinical trials for Cancer in United States

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

Study ID: NCT05020236

Sponsor

Pfizer

De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA

Study ID: NCT05541016

Sponsor

Mayo Clinic

Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation

Study ID: NCT05417971

Sponsor

Northside Hospital, Inc.

Remote Temperature Monitoring of Patients At Risk for Developing Fever

Study ID: NCT06752512

Sponsor

AION Biosystems

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

Study ID: NCT06450041

Sponsor

New Approaches to Neuroblastoma Therapy Consortium

DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma

Study ID: NCT06504381

Sponsor

University of California, San Francisco

A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer

Study ID: NCT05989828

Sponsor

University of Southern California

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

Study ID: NCT06127407

Sponsor

Servier Bio-Innovation LLC

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

Study ID: NCT02074839

Sponsor

Servier International Research Institute

Epcoritamab-CAR T Cells for Large B-cell Lymphomas

Study ID: NCT06458439

Sponsor

Abramson Cancer Center at Penn Medicine